Literature DB >> 11081305

[Collagen fibrils in nanophthalmic sclerae].

T Fukuchi1, H Abe, S Sawaguchi.   

Abstract

PURPOSE: To examine collagen fibrils in 3 nanophthalmos sclerae and to compare them with normal control sclerae morphometrically.
MATERIALS AND METHODS: Three cases of nanophthalmos associated with uveal effusion were studied. When sclerectomy was performed, scleral specimens were collected and fixed with 3% glutaraldehyde/2.5% paraformaldehyde. After epon-embedding and ultrathin sectioning, they were examined by transmission electron microscopy. Collagen fibrils from both nanophthalmos and normal control sclerae were compared in diameters and numbers per micron 2 areas.
RESULTS: All scleral tissues from the three cases were associated with irregularly woven and unclear collagen bundles. Several abnormal findings, such as twisting or fraying, were also detected in a few collagen fibrils. The diameter and density of normal-appearing collagen fibrils that occupied most areas of nanophthalmos sclerae were the same as those from normal control sclerae morphometrically.
CONCLUSIONS: Although nanophthalmos sclerae even with uveal effusion showed thick irregular collagen bundles and a few abnormal collagen fibrils, most collagen fibrils appeared the same as normal controls.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11081305

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  3 in total

1.  Changes of scleral sulfated proteoglycans in three cases of nanophthalmos.

Authors:  Takeo Fukuchi; Hideko Sawada; Masaaki Seki; Tokuhide Oyama; Hiroyuki Cho; Haruki Abe
Journal:  Jpn J Ophthalmol       Date:  2009-03-31       Impact factor: 2.447

2.  Angle closure in younger patients.

Authors:  Brian M Chang; Jeffrey M Liebmann; Robert Ritch
Journal:  Trans Am Ophthalmol Soc       Date:  2002

3.  Clinical and genetic features of a dominantly-inherited microphthalmia pedigree from China.

Authors:  Changhong Yu; Zhengmao Hu; Jingzhi Li; Ting Liu; Kun Xia; Lixin Xie
Journal:  Mol Vis       Date:  2009-05-08       Impact factor: 2.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.